SCHEMBL7168892

SCHEMBL7168892

COc1ccc(CCN(C)CCc2ccc(NC(=O)c3ccccc3C(N)=O)cc2)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ BLM P54132 1/20 0.54
▸ PMP22 Q01453 1/20 0.54
▸ BCHE P06276 1/20 0.51
▸ ACHE P22303 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ CYP2C8 P10632 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ MAPT P10636 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ SMPD1 P17405 1/20 0.49
▸ ABCB1 P08183 2/20 0.48
▸ ABCG2 Q9UNQ0 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048156 0.94 BCHE (0.54) CYP3A4CYP1A2CYP2D6BLMPMP22
SCHEMBL7168899 0.91 ABCB1 (0.59) CYP3A4CYP1A2CYP2D6BLMPMP22
SCHEMBL4048160 0.85 ABCB1 (0.58) CYP3A4CYP1A2CYP2D6BLMBCHE
SCHEMBL8789562 0.80 ABCG2 (0.69) CYP3A4CYP1A2CYP2D6BLMPMP22
SCHEMBL8808386 0.80 MAPT (0.45) CYP3A4CYP1A2CYP2D6BLMPMP22
SCHEMBL9826705 0.80 ALOX15 (0.69) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL8789662 0.79 ABCG2 (0.64) CYP3A4CYP1A2CYP2D6BLMPMP22
SCHEMBL8789246 0.78 ABCG2 (0.66) CYP3A4CYP1A2CYP2D6KDM4ECYP2C8
SCHEMBL8807015 0.77 ABCG2 (0.44) CYP3A4CYP1A2CYP2D6BLMPMP22
SCHEMBL8789962 0.77 ABCG2 (0.65) CYP3A4CYP1A2CYP2D6ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934276-B1 ANTHRANILIC ACID DERIVATIVES AS MULTI DRUG RESISTANCE MODULATORS XENOVA LTD (GB) 2003-12-17 — — EP claimed
US-6218393-B1 IN THERAPY OF MULTIDRUG RESISTANT CANCERS, FOR EXAMPLE TO POTENTIATE CYTOTOXICITY OF CANCER DRUG XENOVA LIMITED (GB) 2001-04-17 — — US claimed
Send feedback